References
- United Nations Department of Economic and Social Affairs. World economic situation and prospects 2021. New York: United Nations publication; 2021.
- Deroose CM, Lecouvet FE, Collette L, et al. Impact of the COVID-19 crisis on imaging in oncological trials. Eur J Nucl Med Mol Imaging. 2020;47:1–12.
- Caruso C. Clinical research slows as COVID-19 surges. Cancer Discov. 2020;10(5):630.
- Upadhaya S, Yu JX, Oliva C, et al. Impact of COVID-19 on oncology clinical trials. Nat Rev Drug Discov. 2020;19(6):376–377.
- Bagiella E, Bhatt DL, Gaudino M. The consequences of the COVID-19 pandemic on non-COVID-19 clinical trials. J Am Coll Cardiol. 2020;76(3):342–345.
- Chowdhury P, Paul SK, Kaisar S, et al. COVID-19 pandemic related supply chain studies: a systematic review. Transp Res E Logist Transp Rev. 2021;148:102271.
- Wieten S, Burgart A, Cho M. Resource allocation in COVID-19 research: which trials? Which patients? Am J Bioeth. 2020;20(7):86–88.
- Carlisle BG Clinical trials stopped by Covid-19. Accessed 19 May 2021. https://covid19.bgcarlisle.com/.
- van Dorn A. COVID-19 and readjusting clinical trials. Lancet. 2020;396(10250):523–524.
- Rodriguez-Otero P, Reis J, Alfonso-Pierola A, et al. Single-institution experience in clinical trials during the COVID-19 pandemic in Spain: not so bad after all? JCO Glob Oncol. 2020;6:904–905.
- Waterhouse DM, Harvey RD, Hurley P, et al. Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: findings from an American Society of Clinical Oncology survey. JCO Oncol Pract. 2020;16(7):417–421.
- Strujo E, Sanders M, Fiscella K, et al. COVID-19 impact on multi-site recruitment and enrollment. Clin Trials. 2020;17(5):501–504.
- Kent DG, Djhf K, Kannan N. Survey says: “COVID-19 lockdown hits young faculty and clinical trials”. Stem Cell Reports. 2020;15(1):1–5.
- Medidata Solutions Inc. The impact of COVID-19 on clinical trial sites 2020. Accessed 19 May 2021. https://www.medidata.com/en/insight/covid-19-and-clinical-trials-the-medidata-perspective.
- Lee J, Shin HW, Lee JY, et al. A comprehensive analysis of clinical trials in the COVID-19 pandemic era. Medicina (Kaunas). 2020;56(6):315. doi:10.3390/medicina56060315.
- Gaudino M, Arvind V, Hameed I, et al. Effects of the COVID-19 pandemic on active non-COVID clinical trials. J Am Coll Cardiol. 2020;76(13):1605–1606.
- Food and Drug Administration. Food and Drug Administration Amendment Act of 2007. 2007. Accessed 19 May 2021. https://www.govinfo.gov/content/pkg/PLAW-110publ85/html/PLAW-110publ85.htm.
- Stergiopolous S, Getz K, Blazynski C. Evaluating the completeness of ClinicalTrials.gov. Ther Innov Regul Sci. 2019;53(3):307–317.
- Gillen JE, Tse T, Ide NC, et al. Design, implementation and management of a web-based data entry system for ClinicalTrials.gov. Stud Health Technol Inform. 2004;107:1466–1470.
- Perez RP, Finnigan S, Patel K, et al. Clinical trial electronic portals for expedited safety reporting: recommendations from the clinical trials transformation initiative investigational new drug safety advancement project. JMIR Cancer. 2016;2(2):e16.
- U.S. National Library of Medicine. Medical Subject Headings 2021. Accessed 19 May 2021. https://meshb.nlm.nih.gov/search.
- O’Hara-Wild M, Hyndman R, Wang E, et al. fable: forecasting models for tidy time series 2021.Accessed 19 May 2021. https://cran.r-project.org/web/packages/fable/index.html.
- Hyndman RJ, Athanasopoulos G. Forecasting: principles and practice. 3rd ed. Melbourne Australia: OTexts; 2021.
- Dziak JJ, Coffman DL, Lanza ST, et al. Sensitivity and specificity of information criteria. Brief Bioinform. 2020;21(2):553–565.
- R Core Team. R: a language and environment for statistical computing Vienna Austria: R Foundation for Statistical Computing; 2021.Accessed 19 May 2021. https://www.R-project.org/.
- Unger JM, Xiao H. The COVID-19 pandemic and new clinical trial activations. Trials. 2021;22(1):260.
- United Nations Department of Economic and Social Affairs. World economic situation and prospects 2020. New York: United Nations publication; 2020.
- Hufsky F, Lamkiewicz K, Almeida A, et al. Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research. Brief Bioinform. 2021;22(2):642–663.
- Byrd JB, Bello N, Meyer MN. Pandemic pandemonium: pausing clinical research during the COVID-19 outbreak. Circulation. 2020;141(25):2045–2047.
- Goldsack JC, Izmailova ES, Menetski JP, et al. Remote digital monitoring in clinical trials in the time of COVID-19. Nat Rev Drug Discov. 2020;19(6):378–379.
- McDermott MM, Newman AB. Preserving clinical trial integrity during the coronavirus pandemic. Jama. 2020;323(21):2135–2136.
- Food and Drug Administration. Conduct of clinical trials of medical products during the COVID-19 public health emergency 2020 [updated Jan 2021. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency.
- European Medicines Agency. Guidance on the management of clinical trials during the COVID-19 (coronavirus) pandemic 2020 [updated Feb 2021. Available from: https://www.ema.europa.eu/en/news/guidance-sponsors-how-manage-clinical-trials-during-covid-19-pandemic.
- Xue JZ, Smietana K, Poda P, et al. Clinical trial recovery from COVID-19 disruption. Nat Rev Drug Discov. 2020;19(10):662–663.
- Gaba P, Bhatt DL. The COVID-19 pandemic: a catalyst to improve clinical trials. Nat Rev Cardiol. 2020;17(11):673–675.
- MacKenzie R, Honig P, Sewards J, et al. COVID-19 must catalyse changes to clinical development. Nat Rev Drug Discov. 2020;19(10):653–654.
- Mitchell EJ, Ahmed K, Breeman S, et al. It is unprecedented: trial management during the COVID-19 pandemic and beyond. Trials. 2020;21(1):784.
- OCED. Greater harmonisation of clinical trial regulations would help the fight against COVID-19. 2020. Accessed 19 May 2021. https://www.oecd.org/coronavirus/policy-responses/greater-harmonisation-of-clinical-trial-regulations-would-help-the-fight-against-covid-19-732e1c5c/.
- ClinicalTrials.gov. Updated quality control and posting procedures. 2019. Accessed 19 May 2021. https://prsinfo.clinicaltrials.gov/webinars/Webinar_Posting_Summary_Results_within_30_days.pdf.